Cited by 561Ovarian function and disordersMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Open access

Dunaif, A, Xia, J, Book, C B, Schenker, E, Tang, Z·1995·Journal of Clinical Investigation

DOI 10.1172/jci118126PMC PMC185266

Open this paper in CoChat — free account Open PDF

Abstract

We investigated the cellular mechanisms of the unique disorder of insulin action found in the polycystic ovary syndrome (PCOS). Approximately 50% of PCOS women (PCOS-Ser) had a significant increase in insulin-independent beta-subunit [32P]phosphate incorporation (3.7-fold, P < 0.05 vs other groups) in skin fibroblast insulin receptors that was present in serine residues while insulin-induced tyrosine phosphorylation was decreased (both P < 0.05 vs other groups). PCOS skeletal muscle insulin receptors had the same abnormal phosphorylation pattern. The remaining PCOS women (PCOS-n1) had basal and insulin-stimulated receptor autophosphorylation similar to control. Phosphorylation of the artificial substrate poly GLU4:TYR1 by the PCOS-Ser insulin receptors was significantly decreased (P < 0.05) compared to control and PCOS-n1 receptors. The factor responsible for excessive serine phosphorylation appeared to be extrinsic to the receptor since no insulin receptor gene mutations were identified, immunoprecipitation before autophosphorylation corrected the phosphorylation defect and control insulin receptors mixed with lectin eluates from affected PCOS fibroblasts displayed increased serine phosphorylation. Our findings suggest that increased insulin receptor serine phosphorylation decreases its protein tyrosine kinase activity and is one mechanism for the post-binding defect in insulin action characteristic of PCOS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci118126

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L., Dull, T. J., Gray, A., Coussens, L. M., Liao, Y.-C., Tsubokawa, M., et al. (1985) · Nature · doi:10.1038/313756a0 · Cited by 2,251
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Self-citation
Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.
Ullrich, A., Gray, A., Tam, A. W., Yang‐Feng, T. L., Tsubokawa, M., Collins, C. M., Henzel, W. J., Bon, T. L., Kathuria, S., & Chen, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04528.x · Cited by 1,843
[42] Detection and quantification of phosphotyrosine in proteins
Cooper, J. A., Sefton, B. M., & Hunter, T. R. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)99075-4 · Cited by 1,109
Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Insulin Action, Diabetogenes, and the Cause of Type II Diabetes
Kahn, C. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1066 · Cited by 916
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
POLSON, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 899
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624

Flagged first, then by citations

Show all 71 references

Sorted by citations

Items 201–300 of 559

Adipose Tissue Hormones and Appetite and Body Weight Regulators an Insulin Resistance / Гормоны Жировой Ткани И Регуляторы Аппетита И Массы Тела При Инсулиновой Резистентности
Koleva, D. I., Orbetzova, M. M., & Atanassova, P. K. (2013) · Folia Medica · doi:10.2478/folmed-2013-0002 · Cited by 49
Polycystic Ovary Syndrome and the Metabolic Syndrome
Sharpless, J. L. (2003) · Clinical Diabetes · doi:10.2337/diaclin.21.4.154 · Cited by 49
Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
Dhindsa, G., Bhatia, R., Dhindsa, M., & Bhatia, V. (2004) · PubMed · Cited by 48
Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome
Batukan, C., & Baysal, B. (2001) · Archives of Gynecology and Obstetrics · doi:10.1007/s004040100176 · Cited by 48
Leptin, polycystic ovaries and polycystic ovary syndrome
Jacobs, H. S. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.2.166 · Cited by 48
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
Jensterle, M., Janez, A., Mlinar, B., Marc, J., Prezelj, J., & Pfeifer, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0857 · Cited by 47
Genomic variants in polycystic ovary syndrome
Luque‐Ramírez, M., Millán, J. L. S., & Escobar-Morreale, H. F. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.017 · Cited by 48
PI 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes
Zhang, B. B. (2002) · Frontiers in bioscience · doi:10.2741/a820 · Cited by 47
Molecular Mysteries of Polycystic Ovary Syndrome
Strauss, J. F., & Dunaif, A. E. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0285 · Cited by 47
Self-citation
Metformin alters insulin signaling and viability of human granulosa cells
Sonntag, B., Götte, M., Wülfing, P., Schüring, A. N., Kiesel, L., & Greb, R. R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.04.043 · Cited by 47
Polycystic Ovarian Syndrome in Women with Epilepsy: A Review
Duncan, S. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.042suppl.3060.x · Cited by 47
INSULIN-LOWERING THERAPEUTIC MODALITIES FOR POLYCYSTIC OVARY SYNDROME
Ehrmann, D. A. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70078-5 · Cited by 47
Determinants of Impaired Fasting Glucose Versus Glucose Intolerance in Polycystic Ovary Syndrome
Karakas, S. E., Kim, K., & Dulęba, A. J. (2010) · Diabetes Care · doi:10.2337/dc09-1525 · Cited by 51
Insulin resistance and metformin in polycystic ovary syndrome
Ben‐Haroush, A., Yogev, Y., & Fisch, B. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2003.11.027 · Cited by 47
Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids
Cree‐Green, M., Newcomer, B. R., Coe, G. V., Newnes, L., Baumgartner, A., Brown, M. S., Pyle, L., Reusch, J. E. B., & Nadeau, K. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00619.2014 · Cited by 45
Lipid Accumulation Product is Related to Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Xiang, S., Hua, F., Chen, L., Tang, Y., Jiang, X., & Liu, Z. (2013) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1333261 · Cited by 44
The role of advanced glycation end products in human infertility
Zhu, J., Cai, Y.-Q., Long, S.-L., Chen, Z., & Mo, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117830 · Cited by 44
The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis
Mor, E., Zograbyan, A., Saadat, P., Bayrak, A., Tourgeman, D. E., Zhang, C., Stanczyk, F. Z., & Paulson, R. J. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.02.052 · Cited by 44
Metformin in Obstetric and Gynecologic Practice: A Review
McCarthy, E. A., Walker, S. P., McLachlan, K., Boyle, J., & Permezel, M. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000109224.52893.b8 · Cited by 44
Polycystic Ovary Syndrome
Sood, M., Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_33 · Cited by 43
The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial
Jafari-Sfidvajani, S. J., Ahangari, R., Hozoori, M., Mozaffari–Khosravi, H., Fallahzadeh, H., & Nadjarzadeh, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0785-9 · Cited by 43
Endothelial Function Varies According to Insulin Resistance Disease Type
Beckman, J. A., Goldfine, A. B., Dunaif, A. E., Gerhard‐Herman, M. D., & Creager, M. A. (2007) · Diabetes Care · doi:10.2337/dc06-2142 · Cited by 42
Self-citation
The Regulation of Human P450c17 Activity: Relationship to Premature Adrenarche, Insulin Resistance and the Polycystic Ovary Syndrome
Auchus, R. J., Geller, D. H., Lee, T. C., & Miller, W. L. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00016-2 · Cited by 42
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 41
[Genetic aspects of polycystic ovary syndrome].
Jakubowski, L. (2005) · PubMed · Cited by 40
Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance
Fedorcsák, P., Storeng, R., Dale, P. O., Tanbo, T. G., & Åbyholm, T. (2000) · Gynecological Endocrinology · doi:10.3109/09513590009167701 · Cited by 40
Membrane glycoprotein PC-1 and insulin resistance
Goldfine, I. D., Maddux, B. A., YOUNGREN, J. F., Frittitta, L., Trischitta, V., & Dohm, G. L. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006878001180 · Cited by 40
Effect of Non‐Surgical Periodontal Therapy Along With Myo‐Inositol on High‐Sensitivity C‐Reactive Protein and Insulin Resistance in Women With Polycystic Ovary Syndrome and Chronic Periodontitis: A Randomized Controlled Trial
Deepti, Tewari, S., Narula, S. C., Singhal, S. R., & Sharma, R. K. (2017) · Journal of Periodontology · doi:10.1902/jop.2017.170121 · Cited by 39
Genetics of polycystic ovary syndrome
Franks, S., Gharani, N., Waterworth, D. M., Batty, S., White, D. M., Williamson, R., & McCarthy, M. I. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00178-6 · Cited by 39
Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment
Tao, T., Wu, P., Wang, Y., & Liu, W. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0243-5 · Cited by 38
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
Pani, A., Gironi, I., Di Vieste, G., Mion, E., Bertuzzi, F., & Pintaudi, B. (2020) · International Journal of Endocrinology · doi:10.1155/2020/6276187 · Cited by 38
The serine phosphorylations in the IRS-1 PIR domain abrogate IRS-1 and IR interaction
Woo, J. R., Bae, S.-H., Wales, T. E., Engen, J. R., Lee, J., Jang, H., & Park, S. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2401716121 · Cited by 41
Relationship between insulin resistance and gonadotropin dissociation in obese and nonobese women with polycystic ovary syndrome
Morán, C., García-Hernández, E., Barahona, E., González, S., & BERMUDEZ, J. A. (2003) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.05.010 · Cited by 38
Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-γ2 Pro12Ala genotype
Tok, E. C., Aktas, A., Ertunç, D., Erdal, M. E., & Dilek, S. (2005) · Human Reproduction · doi:10.1093/humrep/deh769 · Cited by 37
Role of hyperinsulinemia on hepatic insulin receptor concentration and autophosphorylation in the presence of high growth hormone levels in transgenic mice overexpressing growth hormone gene
Dominici, F. P., Balbis, A., Bartke, A., & Turyn, D. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590015 · Cited by 37
Hiperandrogenismo e pele: síndrome do ovário policístico e resistência periférica à insulina
Yarak, S., Bagatin, E., Hassun, K. M., Parada, M. B., & Talarico, S. (2005) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962005000400011 · Cited by 36
Impaired Insulin Activation and Dephosphorylation of Glycogen Synthase in Skeletal Muscle of Women with Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
Glintborg, D., Højlund, K., Andersen, N. R., Hansen, B. F., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0760 · Cited by 37
The Role Of The Adrenal Cortex In Polycystic Ovary Syndrome
Morán, C., & Azziz, R. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70185-6 · Cited by 36
Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome
Orabi, H. E., Ghalia, A. A., Khalifa, A., Mahfouz, H., Shalkani, A. E., & Shoieb, N. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00091-5 · Cited by 36
Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences
Kousta, E., Tolis, G., & Franks, S. (2005) · HORMONES · doi:10.14310/horm.2002.11151 · Cited by 35
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903190699 · Cited by 35
Insulin Resistance in the Polycystic Ovary Syndrome
Dunaif, A. E., & Book, C. B. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-3906-0_14 · Cited by 35
Self-citation
Stress in Women
Diamanti‐Kandarakis, E., & Economou, F. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.006 · Cited by 35
Polycystic ovary syndrome in men: Stein–Leventhal syndrome revisited
Kurzrock, R., & Cohen, P. R. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.03.057 · Cited by 35
Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications
Taylor, A. E. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70239-x · Cited by 35
Insulin and polycystic ovary syndrome: A new look at an old subject
Ciampelli, M., & Lanzone, A. (1998) · Gynecological Endocrinology · doi:10.3109/09513599809015601 · Cited by 34
Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study
Şahin, İ., Serter, R., Karakurt, F., Demirbas, B. T., Çulha, C., Taşkapan, Ç., Koşar, F., & Aral, Y. (2004) · Gynecological Endocrinology · doi:10.1080/09513590400004736 · Cited by 34
The pathogenesis of polycystic ovary syndrome: Lessons from ovarian stimulation studies
Barnes, R. B. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350782 · Cited by 34
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome
Fusco, A., Bianchi, A., Mancini, A., Milardi, D., Giampietro, A., Cimino, V., Porcelli, T., Romualdi, D., Guido, M., Lanzone, A., et al. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03349243 · Cited by 33
Molecular characterization of extracellular vesicles derived from follicular fluid of women with and without PCOS: integrating analysis of differential miRNAs and proteins reveals vital molecules involving in PCOS
Yang, Y., Lang, P., Zhang, X., Wu, X., Cao, S., Zhao, C. L., Shen, R., Ling, X., Yang, Y., & Zhang, J. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02724-z · Cited by 32
Insulin Resistance in PCOS
Diamanti‐Kandarakis, E., & Christakou, C. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_4 · Cited by 32
Selecting controls is not selecting “normals”: Design and analysis issues for studying the etiology of polycystic ovary syndrome
Bloom, M. S., Schisterman, E. F., & Hediger, M. L. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.066 · Cited by 32
No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome
Söderlund, D., Canto, P., Carranza‐Lira, S., & Méndez, J. P. (2005) · Human Reproduction · doi:10.1093/humrep/deh690 · Cited by 32
Female infertility in the era of obesity: The clash of two pandemics or inevitable consequence?
Medenica, S., Spoltore, M. E., Ormazabal, P., Marina, L., Šojat, A. S., Faggiano, A., Gnessi, L., Mazzilli, R., & Watanabe, M. (2022) · Clinical Endocrinology · doi:10.1111/cen.14785 · Cited by 32
Contemporary medical therapy for polycystic ovary syndrome
Lanham, M. S. M., Lebovic, D. I., & Domino, S. E. (2006) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2006.08.004 · Cited by 31
The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome
Ertunç, D., Tok, E. C., Aktas, A., Erdal, M. E., & Dilek, S. (2005) · Human Reproduction · doi:10.1093/humrep/deh747 · Cited by 31
Role of PC‐1 in The Etiology of Insulin Resistance
Goldfine, I. D., Maddux, B. A., YOUNGREN, J. F., Trischitta, V., & Frittitta, L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07797.x · Cited by 32
Metformin and Polycystic Ovary Syndrome: A Literature Review
Awartani, K. A., & Cheung, A. P. (2002) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30402-9 · Cited by 31
Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome
Hanna, F., Wu, P., Heald, A. H., & Fryer, A. A. (2023) · BMJ · doi:10.1136/bmj-2022-071675 · Cited by 31
Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
Wongwananuruk, T., Rattanachaiyanont, M., Indhavivadhana, S., Leerasiri, P., Techatraisak, K., Tanmahasamut, P., Angsuwathana, S., & Dangrat, C. (2012) · International Journal of Endocrinology · doi:10.1155/2012/529184 · Cited by 30
Regulation of androgen biosynthesis—a short review and preliminary results from the hyperandrogenic starvation NCI-H295R cell model
Kempná, P., Marti, N., Udhane, S., & Flück, C. E. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.015 · Cited by 29
The impact of prenatal exposure to a single dose of testosterone on insulin resistance, glucose tolerance and lipid profile of female rat’s offspring in adulthood
Noroozzadeh, M., Tehrani, F. R., Sedaghat, K., Godini, A., & Azizi, F. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0198-y · Cited by 29
The Effects of Short-Term Medroxyprogesterone Acetate and Micronized Progesterone on Glucose Metabolism and Lipid Profiles in Patients with Polycystic Ovary Syndrome: A Prospective Randomized Study
Bağış, T., Gökçel, A., Zeyneloğlu, H. B., Tarım, E., Kılıçdağ, E. B., & Haydardedeoğlu, B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020294 · Cited by 30
Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome
Ciaraldi, T. P., Morales, A. J., Hickman, M. G., Odom-Ford, R., Yen, S. S. C., & Olefsky, J. M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90348-1 · Cited by 29
The long term health consequences of polycystic ovary syndrome
Kelly, C. J., Connell, J., Cameron, I. T., Gould, G. W., & Lyall, H. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11644.x · Cited by 29
Local recruitment experience in a study comparing the effectiveness of a low glycaemic index diet with a low calorie healthy eating approach at achieving weight loss and reducing the risk of endometrial cancer in women with polycystic ovary syndrome (PCOS)
Atiomo, W., Read, A., Golding, M., Silcocks, P., Razali, N., Sarkar, S., Hardiman, P., & Thornton, J. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.05.001 · Cited by 28
Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
Wang, D., & He, B. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s362424 · Cited by 28
Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS
Eriksen, M. B., Pørneki, A. D., Skov, V., Burns, J. S., Beck‐Nielsen, H., Glintborg, D., & Gaster, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014469 · Cited by 29
New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro, A. (2006) · PubMed · Cited by 28
Treatment of the adolescent patient with polycystic ovary syndrome
Pfeifer, S. M., & Dayal, M. B. (2003) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(03)00028-7 · Cited by 28
Impairment in insulin sensitivity after early androgenization in the post-pubertal female rat
Perelló, M., Castrogiovanni, D. C., Giovambattista, A., Gaillard, R. C., & Spinedi, E. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.013 · Cited by 28
Enzymatic Activities of P450c17 Stably Expressed in Fibroblasts from Patients with the Polycystic Ovary Syndrome
Martens, J. W. M., Geller, D. H., Arlt, W., Auchus, R. J., Ossovskaya, V., Rodriguez, H., Dunaif, A. E., & Miller, W. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6971 · Cited by 29
Self-citation
Association of Insulin Resistance with Hyperandrogenia in Women
PUGEAT, M. M., Ducluzeau, P., & Mallion-Donadieu, M. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053281 · Cited by 28
Metabolic Lessons from the Study of Young Adolescents with Polycystic Ovary Syndrome--Is Insulin, Indeed, the Culprit?
Oberfield, S. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6959 · Cited by 28
Obesity, Metabolic Syndrome and Disorders of Energy Balance
Han, J. C., & Weiss, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00024-5 · Cited by 27
Loss of PKBβ/Akt2 predisposes mice to ovarian cyst formation and increases the severity of polycystic ovary formation in vivo
Restuccia, D. F., Hynx, D., & Hemmings, B. A. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008136 · Cited by 27
Polycystic Ovary Syndrome
Kahn, J. A. (2008) · Elsevier eBooks · doi:10.1016/b978-032304073-0.10023-8 · Cited by 27
The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus
Rojas, J., Chávez-Castillo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/797681 · Cited by 26
Pro12Ala polymorphism of theperoxisome proliferator-activated receptor-γgene in first-degree relatives of subjects with polycystic ovary syndrome
Yılmaz, M., Ergün, M. A., Karakoç, A., Yurtçu, E., Yetkin, İ., Ayvaz, G., Çakır, N., & Arslan, M. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500231593 · Cited by 26
The polycystic ovary syndrome: the first 150 years of study
Adashi, E. Y., Cibula, D., Peterson, M., & Azziz, R. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.12.002 · Cited by 27
Ovarian Hyperandrogenism Is Associated with Insulin Resistance to Both Peripheral Carbohydrate and Whole-Body Protein Metabolism in Postpubertal Young Females: A Metabolic Study
Mauras, N., Welch, S., Rini, A., & Haymond, M. W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4866 · Cited by 25
Adrenal Hyperandrogenism in Children
Ghizzoni, L. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4431 · Cited by 25
A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
Glintborg, D., Hermann, A. P., Hagen, C., Jensen, L. T., Frystyk, J., Bennett, P., Flyvbjerg, A., & Andersen, M. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.082 · Cited by 25
Insulin Resistant States and Insulin Signaling
Vollenweider, P. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.173 · Cited by 26
The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7 · Cited by 25
Dephosphorylation increases insulin-stimulated receptor kinase activity in skeletal muscle of obese Zucker rats
Zhou, Q., Dolan, P. L., & Dohm, G. L. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006942831223 · Cited by 25
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia
Ciotta, L., Leo, V. D., Galvani, F., Marca, A. L., & Cianci, A. (1999) · Human Reproduction · doi:10.1093/humrep/14.12.2951 · Cited by 25
Insulin resistance and the polycystic ovary syndrome: recent advances
Nestler, J. E. (2000) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200012000-00009 · Cited by 24
Hyperandrogenic anovulation (the polycystic ovary syndrome) - back to the ovary?
Ben‐Shlomo, I. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.3.296 · Cited by 24
Polycystic ovary syndrome (PCOS), insulin resistance and insulin-like growth factors (IGfs)/IGF-binding proteins (IGFBPs).
Wang, H., & Wang, T. (2003) · PubMed · Cited by 24
Involvement of growth factors in the pathophysiology of polycystic ovary syndrome
Homburg, R. (1998) · Gynecological Endocrinology · doi:10.3109/09513599809012841 · Cited by 24
Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome
Huang‐Doran, I., & Franks, S. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00053 · Cited by 23
Decreased muscle insulin receptor kinase correlates with insulin resistance in normoglycemic Pima Indians
YOUNGREN, J. F., Goldfine, I. D., & Pratley, R. E. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.2.e276 · Cited by 23
Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome
Morán, C., Franco, M. R. H., Conway-Myers, B. A., Hines, G. A., & Azziz, R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01769-6 · Cited by 23
Genetic overlap between polycystic ovary syndrome and bipolar disorder: The endophenotype hypothesis
Jiang, B., Kenna, H. A., & Rasgon, N. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.056 · Cited by 22
Parametrial Adipose Tissue and Metabolic Dysfunctions Induced by Fructose‐rich Diet in Normal and Neonatal‐androgenized Adult Female Rats
Alzamendi, A., Castrogiovanni, D. C., Ortega, H. H., Gaillard, R. C., Giovambattista, A., & Spinedi, E. (2009) · Obesity · doi:10.1038/oby.2009.255 · Cited by 22
Lean mass and insulin resistance in women with polycystic ovary syndrome
Comerford, K. B., Almario, R. U., Kim, K., & Karakas, S. E. (2012) · Metabolism · doi:10.1016/j.metabol.2012.02.004 · Cited by 22
Metabolic Disturbance in PCOS: Clinical and Molecular Effects on Skeletal Muscle Tissue
Dantas, W. S., Gualano, B., Rocha, M. P., Barcellos, C. R. G., Yance, V. D. R. V., & Marcondes, J. A. M. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/178364 · Cited by 22
Insulin Resistance in the Polycystic Ovary Syndrome
Book, C.-B. S., & Dunaif, A. E. (1996) · Springer eBooks · doi:10.1007/978-1-4613-8483-0_8 · Cited by 21
Self-citation
Serum Leptin Elevation in Obese Women with PCOS: A Continuing Controversy
Saleh, H. A., El-Nwaem, M. A., Elbordiny, M., Maqlad, H. M. E.-S., El-Mohandes, A. A., & Eldaqaq, E. M. (2004) · Journal of Assisted Reproduction and Genetics · doi:10.1023/b:jarg.0000046204.81682.67 · Cited by 21

Authors: Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z.
Affiliations: Pennsylvania State University (US)
ORCID: Dunaif, A
Schenker, E
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1995-08-01
Volume: 96
Issue: 2
Pages: 801-810
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci118126
PMC: PMC185266
OpenAlex: W2124838987
Cited by: 561
References: 71
Citations by year: 2026: 3 · 2025: 15 · 2024: 7 · 2023: 17 · 2022: 20 · 2021: 18 · 2020: 15 · 2019: 6 · 2018: 9 · 2017: 13 · 2016: 8 · 2015: 19 · 2014: 18 · 2013: 23 · 2012: 21
FWCI: 18.65
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605, R01 DK-40605)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: polycystic ovary syndrome, insulin resistance, insulin receptor, serine phosphorylation, tyrosine phosphorylation, receptor autophosphorylation, protein tyrosine kinase activity, dermal fibroblasts, skeletal muscle, insulin signaling
MeSH terms: Adult, Blood Glucose, Cells, Cultured, Diabetes Mellitus, Type 2, Female, Fibroblasts, Humans, Insulin, Insulin Resistance, Obesity, Peptides, Phosphorylation, Phosphoserine, Polycystic Ovary Syndrome, Protein Processing, Post-Translational, Receptor, Insulin, Skin, Protein Serine-Threonine Kinases, Muscle, Skeletal, Intercellular Signaling Peptides and Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks